BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 12, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 8, 2016
View Archived Issues
Mice homozygous for LGMD2I-causing FKRP mutation show progressive myopathy
Read More
Genetic association meta-analysis identifies 10 novel risk loci for atopic dermatitis
Read More
X-Chem and MD Anderson partner to discover and develop novel cancer therapies
Read More
Merck & Co. forms partnership with BH4 pathway modulator developer Quartet Medicine
Read More
AGTC and BCM Families Foundation collaborate on AAV-based gene therapy for blue cone monochromacy
Read More
BioAtla and Sinobioway select first programs under CAB collaboration in China
Read More
EMA will review Trevyent under centralized authorization procedure
Read More
U.S. Army starts phase I trial of dengue challenge virus
Read More
OBI Pharma's immunotherapy OBI-833 enters first-in-human trial
Read More
First patient treated in I trial of SBP-101 for pancreatic cancer
Read More
Faron Pharmaceuticals reports topline results from phase II study of Traumakine
Read More
Clearside Biomedical reports topline data from phase II study of CLS-TA
Read More
Ionis Pharmaceuticals' IONIS-HTT Rx receives FDA orphan drug designation
Read More
First-in-class Dub inhibitor shows preclinical antitumor activity
Read More
Millendo licenses phase II polycystic ovary syndrome candidate from AstraZeneca
Read More
Universite Pierre et Marie Curie discloses DNA gyrase inhibitors
Read More
Katholieke Universiteit Leuven and UCB present PI4KIII inhibitors
Read More
State University of New Jersey reports antibacterial compounds
Read More
New U.K. study investigates tocilizumab for PAH
Read More
SYK inhibitor shows acceptable safety profile in patients with DLBCL and FL
Read More
Paratek expects results from phase III trial of omadacycline in ABSSSI in mid-2016
Read More
FDA grants fast track designation to Bendavia for primary mitochondrial myopathy
Read More
Novo Nordisk seeks European approval for nonacog beta pegol for hemophilia B
Read More
Anacor submits NDA for crisaborole for atopic dermatitis
Read More
FDA accepts for review sarilumab BLA for rheumatoid arthritis
Read More
FDA grants orphan drug and breakthrough therapy designations to setmelanotide
Read More
FDA clears IND application for pediatric trial of TB-403
Read More
FDA grants priority review for sNDA for Viekira Pak in genotype 1b HCV and cirrhosis
Read More